Trials / Completed
CompletedNCT03466086
Clinical Evaluation of Two Marketed Artificial Tears in Non-contact Lens Wearing Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 57 (actual)
- Sponsor
- Johnson & Johnson Vision Care, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 69 Years
- Healthy volunteers
- Accepted
Summary
This clinical study is a randomized, double-masked, cross-over, bilateral, 2 treatment x 2 period, dispensing 4-visit study with a 7-9 day washout period in between visits 2 and 3. The study will last approximately 3 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Test Eye Drops | blink® intensive TRIPLE ACTION 3 in 1 eye drops |
| DEVICE | Control Eye Drops | Systane® BALANCE eye drops |
Timeline
- Start date
- 2018-02-09
- Primary completion
- 2018-05-16
- Completion
- 2018-05-16
- First posted
- 2018-03-15
- Last updated
- 2019-06-28
- Results posted
- 2019-05-29
Locations
1 site across 1 country: United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03466086. Inclusion in this directory is not an endorsement.